Redeye's provides its initial take on Oncopeptides’ year-end report, which came in slightly softer t...
Redeye provides a short comment on Ortoma’s Q4 report this morning.
Solwers’ Q4 sales of EUR 21.7m were fairly in line with our estimate of EUR 22.
Redeye comments on Verve Group’s Q4 2024 results, which came in stronger than expected across the bo...
Føroya Banki reported a soft Q4, as profit before loan losses landed at DKK 46m, DKK 8m (6%) below o...
First Venture Sweden (”First Venture” eller ”Bolaget”) är ett investmentbolag med fokus på snabbväxa...
Analyst Group initiates equity research coverage on HydrogenPro (“HydrogenPro” or “the Company”), wh...
- Adj. EBIT 31% vs cons, 51% vs ABG - Order backlog +10% y-o-y, slightly weaker than expected - We e...
Redeye comments on Alligator Bioscience’s 24-month survival numbers, which are superior to historica...
Redeye provides its comments on Enviro’s Q4 report.
Q4 profit before loan losses came in at DKK 46m, DKK 8m (6%) below our estimate.
'25 guidance ~50% below (likely due to delayed ramp-up of IPU volumes) One new design (~2k units), o...
Även om vi bibehåller vår positiva syn på Elon inför 2025 och framåt har vi sänkt våra förväntningar...
Redeye returns with more flesh on the bone regarding the Q4 report.
Lönsamhet och starkt kassaflöde Nettoomsättningen minskade med 8,2 procent, drivet av en fortsatt ut...
Redeye provides comments regarding the recent news flow from Dala Energi, who has recently issued ca...
Top-line revisions partly mitigated by lower funding costs Set to outperform the sector on cash earn...
Sales from the latest US ASTar contract are to be recorded in Q1, which is positive as it adds momen...
EcoRub publicerade den 24 februari 2025 bolagets delårsrapport för det fjärde kvartalet år 2024.
Titania Holding AB (”Titania” eller ”Bolaget”) är en bostadsutvecklare med exponering mot Stockholms...
